DAA1429 |
ribonucleotide reductase M2 |
Molecular |
hippocampus |
Mouse |
Rrm2 |
14.0% Decrease Gene Expression Level |
|
DAA1427 |
ras homolog gene family, member B |
Molecular |
hippocampus |
Mouse |
Rhob |
2.0% Increase Gene Expression Level |
|
DAA1428 |
Ras and Rab interactor 2 |
Molecular |
hippocampus |
Mouse |
Rin2 |
7.0% Increase Gene Expression Level |
|
DAA1421 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
Molecular |
hippocampus |
Mouse |
Pdk4 |
6.0% Increase Gene Expression Level |
|
DAA1424 |
protein tyrosine phosphatase, receptor type, O |
Molecular |
hippocampus |
Mouse |
Ptpro |
5.0% Decrease Gene Expression Level |
|
DAA1393 |
progressive ankylosis |
Molecular |
hippocampus |
Mouse |
Ank |
1.0% Increase Gene Expression Level |
|
DAA1420 |
programmed cell death 4 |
Molecular |
hippocampus |
Mouse |
Pdcd4 |
2.0% Increase Gene Expression Level |
|
DAA1423 |
peptidoglycan recognition protein 1 |
Molecular |
hippocampus |
Mouse |
Pglyrp1 |
8.0% Increase Gene Expression Level |
|
DAA1422 |
pellino 1 |
Molecular |
hippocampus |
Mouse |
Peli1 |
3.0% Increase Gene Expression Level |
|
DAA2352 |
Pannexin 2 decreases with age |
Molecular |
hippocampus |
Human |
PANX2 |
19.1% Decrease Gene Expression Level |
|
DAA1419 |
oncostatin M receptor |
Molecular |
hippocampus |
Mouse |
Osmr |
9.0% Increase Gene Expression Level |
|
DAA1418 |
neuropeptide Y |
Molecular |
hippocampus |
Mouse |
Npy |
3.0% Increase Gene Expression Level |
|
DAA2036 |
Neural stem cell pool declines |
Physiological |
hippocampus |
Mouse |
— |
— |
|
DAA1389 |
N-acetyltransferase 15 (GCN5-related, putative) |
Molecular |
hippocampus |
Mouse |
Nat15 |
1.0% Decrease Gene Expression Level |
|
DAA2216 |
myeloid differentiation primary response gene (88) increases with age |
Molecular |
hippocampus |
Human |
MYD88 |
59.3% Increase Gene Expression Level |
|
DAA1416 |
mannose-P-dolichol utilization defect 1 |
Molecular |
hippocampus |
Mouse |
Mpdu1 |
3.0% Increase Gene Expression Level |
|
DAA2335 |
major histocompatibility complex, class I-related increases with age |
Molecular |
hippocampus |
Human |
MR1 |
46.6% Increase Gene Expression Level |
|
DAA2163 |
major histocompatibility complex, class II, DR beta 6 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB6 |
150.2% Increase Gene Expression Level |
|
DAA2362 |
major histocompatibility complex, class II, DR beta 5 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB5 |
184.0% Increase Gene Expression Level |
|
DAA2361 |
major histocompatibility complex, class II, DR beta 4 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB4 |
177.7% Increase Gene Expression Level |
|
DAA2135 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB1 |
193.5% Increase Gene Expression Level |
|
DAA2360 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB1 |
204.2% Increase Gene Expression Level |
|
DAA2359 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
hippocampus |
Human |
HLA-DRA |
324.5% Increase Gene Expression Level |
|
DAA2317 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
hippocampus |
Human |
HLA-DRA |
317.7% Increase Gene Expression Level |
|
DAA2358 |
major histocompatibility complex, class II, DQ beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DQB1 |
135.4% Increase Gene Expression Level |
|